Allen Capital Group LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Allen Capital Group LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 20.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 530 shares of the healthcare conglomerate’s stock after purchasing an additional 89 shares during the period. Allen Capital Group LLC’s holdings in UnitedHealth Group were worth $279,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Axiom Financial Strategies LLC purchased a new stake in UnitedHealth Group in the 1st quarter worth $210,000. McGowan Group Asset Management Inc. lifted its position in shares of UnitedHealth Group by 8.9% in the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after buying an additional 61 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in UnitedHealth Group by 31.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after acquiring an additional 60,300 shares during the last quarter. MAS Advisors LLC boosted its position in shares of UnitedHealth Group by 10.8% during the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after acquiring an additional 45 shares during the last quarter. Finally, First Western Trust Bank bought a new stake in UnitedHealth Group in the first quarter worth $875,000. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Up 5.3 %

Shares of UnitedHealth Group stock opened at $469.14 on Wednesday. The stock’s fifty day moving average is $490.31 and its 200-day moving average is $515.63. The firm has a market capitalization of $432.51 billion, a PE ratio of 19.68, a price-to-earnings-growth ratio of 1.22 and a beta of 0.54. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.54 by $0.37. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the prior year, the company posted $6.26 EPS. The business’s revenue was up 8.6% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.54%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Bank of America restated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Piper Sandler cut their target price on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. Royal Bank of Canada restated an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 29th. Finally, Barclays began coverage on shares of UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price objective on the stock. Three analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $573.80.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.